ViroCell Biologics Retroviral & Lentiviral Vector CDMO
Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing
Notes from the Inside Viral Vector Science Videos + Webinars Articles
In the News Press Releases Conferences
Careers
Team ViroCell Leadership Team Scientific Advisory Board Board of Directors What we do Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing Innovative thinking Notes from the Inside Viral Vector Science Videos + Webinars Articles
ViroCell Biologics Retroviral & Lentiviral Vector CDMO
News In the News Press Releases Conferences Manufacturing dreams Careers Contact Us
 

Notes from the inside

 
The Lentiviral Comeback: Why LVVs are poised to redefine in vivo gene therapy
The Lentiviral Comeback: Why LVVs are poised to redefine in vivo gene therapy
Florence BuchananAugust 7, 2025
 

Team ViroCell will be on the road

2-4 Sept – Advanced Therapies Week Europe, Barcelona

23-26 Sept – CAR-TCR Summit US, Boston

Webinar

3 Sept – Next-gen vectors: advancing in vivo and ex vivo gene delivery through intelligent design
08:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST

REGISTER HERE
 

If you’re looking for a lentiviral and retroviral vector CDMO, we’d love to connect

Get in touch
videosNewsroomCareersContact UsTerms of UsePrivacy Notice

London New York

 

©2025 ViroCell Biologics, Ltd. All rights reserved.